SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NXTS

Nexentis Technologies Inc. (NASDAQ:NXTS)

IL · Delayed Price · Currency is USD
Basic Materials · Agricultural Inputs
$1.58-$0.12 (-7.06%)
 
Market cap
$751K
Insider Score
Health Score
Listed since
Feb 26, 2026
Market Cap$750.66K-96.9%
Revenue (ttm)-$68.00K-132.6%
Net Income-$11.43M-71.9%
EPS-$24.05+66.0%
Shares Out475.10K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,080
Open$1.74
Previous Close$1.70
Day's Range$1.55 - $1.74
52-Week Range$1.55 - $119.00
Beta1.98
Analystsn/a
Price Targetn/a
Earnings DateMar 3, 2027
-7.06% (1D)
No price history available.

About NXTS

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

Address
Pinhas Sapir St. 3, Ness Ziona, TA, 7403626, IL
Market Cap
1 million
Employees
8
Industrial Classification
Agricultural Inputs

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$172.09
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From NXTS’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-7.06%
5 Days
-26.17%
1 Month
-41.70%
6 Months
-92.85%
1 Year
-96.89%

$NXTS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NXTS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NXTS's directors and management

Net Shares Purchased by Insiders−200−10002025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NXTS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NXTS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NXTS from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NXTS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
1
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.